Fennec Announces Results of Annual Meeting
May 28, 2015 20:28 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - May 28, 2015) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF) today announced that the nominees listed in the management proxy...
Fennec Provides Corporate Update and First Quarter Ended March 31, 2015 Financial Results
May 15, 2015 07:00 ET
|
Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - May 15, 2015) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF), a specialty pharmaceutical company focused on the development of...
Fennec Announces Availability of Siopel 6 Study Abstract for ASCO 2015 Meeting
May 14, 2015 06:00 ET
|
Fennec Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - May 14, 2015) - Fennec Pharmaceuticals, Inc. (TSX:FRX)(OTCQB:FENCF), today announced that sodium thiosulfate (STS) will be featured...
Fennec Pharmaceuticals Announces the Exercise of Warrants by the Company's Largest Shareholder and Provides Updated Corporate Capital Structure
May 04, 2015 07:00 ET
|
Fennec Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - May 4, 2015) - Fennec Pharmaceuticals, Inc. (TSX:FRX)(OTCQB:FENCF), today reported that Southpoint Master Fund, LP ("Southpoint"),...
Southpoint Files Early Warning Report in Connection With Exercise of Warrants in Fennec Pharmaceuticals Inc.
April 29, 2015 13:32 ET
|
Southpoint Master Fund, LP
TORONTO, ONTARIO--(Marketwired - April 29, 2015) - Southpoint Master Fund, LP ("Southpoint") has acquired, by the exercise of 293,511 warrants of Fennec Pharmaceuticals Inc. ("Fennec") at...